Esperante BV Mergers and Acquisitions Summary

Private Equity Profile

Esperante BV’s most common sector for investment is life science (100%). The Firm’s most common investment types include secondary buyout (100%).

Join Mergr to view Esperante BV’s full profile and discover more small private equity firms just like it.

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1

Esperante BV

,
www.esperanteventures.com

Esperante is a privately held investment company focussed on investing in therapeutics, in vitro diagnostics and selected medical device companies. The Firm will consider opportunities throughout Europe and North America. Esperante is based in Hoofddorp, The Netherlands with an additional office in Drayton, England.


Investment Criteria

Sectors of Interest: Life Science

Target Transaction Types: Buyout (LBO, MBO, MBI), Growth Capital, Secondary Buyout, Venture

Geographic Preferences: East US, Midwest US, South US, West US, Canada, United Kingdom, Western Europe, Eastern Europe, Scandinavia

Transaction Criteria Min Max
Target Revenue - -
Target EBITDA - -
Investment Size - -
Enterprise Value - -

M&A Summary

Buy vs Sell

Year ≤ '15 '16 '17 '18 '19 '20 T
Buy (0.0/yr) # 1 - - - - - 1
Sell (0.0/yr) # - - - - - - 0
  1

Most Recent M&A

Company Date Value Type
Altacor Ltd. 2014-07-31 - Secondary Buyout
Cambridge, United Kingdom · www.altacor-pharma.com
View All >>

M&A by Sector

Sector Current # Value All-time # Value
Life Science 1 (100%) - 1 (100%) -
Total 1 - 1 -

Acquisitions By Geo

State/Country Current # Value All-time # Value
United Kingdom 1 (100%) - 1 (100%) -
Total 1 - 1 -

Acquisitions by Deal Type

Type Current # Value All-time # Value
Secondary Buyout 1 (100%) - 1 (100%) -
Total 1 - 1 -

M&A Connections

Deals %
Acquired from
PE Firm(s)
100%
2 100%